Lung Diseases  >>  glufosfamide (D 19575)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
glufosfamide (D 19575) / Eleison Pharma
NCT00435578: Safety and Efficacy Study of Glufosfamide in Patients With Recurrent Sensitive Small Cell Lung Carcinoma

Terminated
2
50
US
Glufosfamide
Threshold Pharmaceuticals
Carcinoma, Small Cell Lung
11/07
11/07

Download Options